MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Senate Sept. 25 voted 78-18 to pass a continuing resolution funding the government through Dec. 20 and avoiding a government shutdown. The House of…
Headline
The AHA Sept. 26 launched a new video series in which former AHA Board Chair Mindy Estes, M.D., has conversations with hospital and health system leaders about…
Headline
The Centers for Medicare & Medicaid Services Sept. 26 released guidance on state compliance with the Early and Periodic Screening, Diagnostic and Treatment…
Headline
Clinical validation audits are a new tactic that certain commercial insurers are adopting to reduce or deny payment to health care providers and can take…
Headline
The Centers for Medicare & Medicaid Services Sept. 24 issued a final rule that would carve out significant, anomalous, and highly suspect (SAHS) billing…
Headline
The House Sept. 25 voted 341-82 to pass a continuing resolution (H.R.9747) funding the government through Dec. 20 and avoiding a government shutdown. The…